An experimental vaccine against Alzheimer’s disease has cleared its first
hurdle. Elan Pharmaceuticals of Dublin announced this week that the first 100
patients to receive the vaccine had not suffered any serious side effects. Some
showed an immune response. Codenamed AN-1792, the vaccine is a synthetic version
of the amyloid protein that clogs up the brains of patients. The company now
plans to test the vaccine in the US and Europe.
To continue reading, today with our introductory offers
Advertisement
More from New Å®ÉúСÊÓƵ
Explore the latest news, articles and features
Life
We may finally know why dinosaurs like T. rex evolved tiny arms
News
Space
The distant world that is our best hope of finding alien life
Features
Environment
Solar farm on the ocean outperforms land-based solar in Taiwan
News
Environment
Wind-assisted cargo ships could more than halve shipping emissions
News
Popular articles
Trending New Å®ÉúСÊÓƵ articles
1
The distant world that is our best hope of finding alien life
2
The ‘doomsday’ glacier’s giant ice shelf is about to break away
3
Mystery of the ancient giant stone jars of Laos may have been solved
4
How I used psychology to come back from the worst year of my life
5
Why autism pioneer Uta Frith wants to dismantle the spectrum
6
Wind-assisted cargo ships could more than halve shipping emissions
7
We may finally know why dinosaurs like T. rex evolved tiny arms
8
Colossal claims an artificial eggshell will help it bring back the moa
9
Solar farm on the ocean outperforms land-based solar in Taiwan
10
Asteroid set to fly very close to Earth
